Ledesma MC - Search Results

1

Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.

Agúndez JA, Martínez C, Olivera M, Ledesma MC, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Clin Pharmacol Ther. 1994 Aug;56(2):202-9. doi: 10.1038/clpt.1994.124. Clin Pharmacol Ther. 1994. PMID: 8062497

2

Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication.

Ledesma MC, Agúndez JA. Ledesma MC, et al. Clin Chem. 2005 Jun;51(6):939-43. doi: 10.1373/clinchem.2004.046326. Epub 2005 Apr 7. Clin Chem. 2005. PMID: 15817819

3

Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population.

Agúndez JA, Ledesma MC, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Clin Pharmacol Ther. 1995 Mar;57(3):265-9. doi: 10.1016/0009-9236(95)90151-5. Clin Pharmacol Ther. 1995. PMID: 7697944

4

CYP2D6 genes and risk of liver cancer.

Agúndez JA, Ledesma MC, Benítez J, Ladero JM, Rodríguez-Lescure A, Díaz-Rubio E, Díaz-Rubio M. Agúndez JA, et al. Among authors: ledesma mc. Lancet. 1995 Apr 1;345(8953):830-1. doi: 10.1016/s0140-6736(95)92965-7. Lancet. 1995. PMID: 7898230

5

Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations.

Agúndez JA, Martínez C, Ledesma MC, Ladona MG, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Clin Pharmacol Ther. 1994 Apr;55(4):412-7. doi: 10.1038/clpt.1994.50. Clin Pharmacol Ther. 1994. PMID: 7909282

6

Debrisoquin oxidation genotype and susceptibility to lung cancer.

Agúndez JA, Martínez C, Ladero JM, Ledesma MC, Ramos JM, Martín R, Rodriguez A, Jara C, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Clin Pharmacol Ther. 1994 Jan;55(1):10-4. doi: 10.1038/clpt.1994.3. Clin Pharmacol Ther. 1994. PMID: 8299311

7

Frequency of CYP2D6 allelic variants in multiple sclerosis.

Agúndez JA, Arroyo R, Ledesma MC, Martínez C, Ladero JM, de Andrés C, Jiménez-Jiménez FJ, Molina JA, Alvarez-Cermeño JC, Varela de Seijas E, et al. Agúndez JA, et al. Among authors: ledesma mc. Acta Neurol Scand. 1995 Dec;92(6):464-7. doi: 10.1111/j.1600-0404.1995.tb00481.x. Acta Neurol Scand. 1995. PMID: 8750111

8

Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.

Agúndez JA, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, Meyer UA, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Pharmacogenetics. 1996 Dec;6(6):501-12. doi: 10.1097/00008571-199612000-00003. Pharmacogenetics. 1996. PMID: 9014199

9

CYP2D6 polymorphism is not associated with essential tremor.

Agúndez JA, Jiménez-Jiménez FJ, Tejeda R, Ledesma MC, Ortí-Pareja M, Gasalla T, Molina JA, Ruiz J, Coria F, Duarte J, Vázquez A, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Eur Neurol. 1997;38(2):99-104. doi: 10.1159/000113168. Eur Neurol. 1997. PMID: 9286632

10

Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients.

Agúndez JA, Gallardo L, Ledesma MC, Lozano L, Rodriguez-Lescure A, Pontes JC, Iglesias-Moreno MC, Poch J, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: ledesma mc. Oncology. 2001;61(1):59-63. doi: 10.1159/000055354. Oncology. 2001. PMID: 11474250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page